Tyber Medical Reaches Agreement to Acquire CatapultMD

Purchase of contract manufacturer's assets will double Tyber's manufacturing footprint to 100,000-square feet

Tyber Medical, since its founding in 2012, has experienced record growth with its continually expanding product portfolio.

In support of its rapid growth, the company implemented a vertical integration strategy, in 2019, that included a large-scale expansion of its headquarters located in the Lehigh Valley in Pennsylvania.

As Tyber Medical continues to expand its customer base and product portfolio, which includes private label orthopedic implants for the trauma, extremity, and spine markets, it will now double its manufacturing capacity upon purchasing all the assets of CatapultMD, based in Bonita Springs, Florida.

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities. The acquisition will expand Tyber Medical’s machining footprint to include over 40 CNC Swiss machines and 10, 5-axis CNC mills for manufacturing plates, screws, spinal implants, and instrumentation used in orthopedic surgery.

With the receipt of two U.S. Food and Drug Administration (FDA) 510(k) clearances for its anatomical plating systems in the last year, Tyber Medical now offers its most comprehensive portfolio of products, since its founding in 2012. “We’ve been on a significant growth trajectory fueled by our expert research and development team, outstanding engineering capability, and our recent FDA clearances,” said Tyber Medical Chief Executive Officer Jeff Tyber. “Our acquisition of CatapultMD’s top-of-the-line CNC automation and inspection capabilities seamlessly aligns with our strict MDSAP and ISO 13485 quality standards and enables us to meet and exceed our growing demand by instantaneously doubling our internal manufacturing and processing capacity.”

The CatapultMD transaction is expected to add up to 24 team members to Tyber’s current workforce of 120, including the co-founders of CatapultMD, Len and Oliver Zaiser. Len Zaiser is well-known through the founding of Structure Medical and well-respected for his unique engineering talent and creativity in using state-of-the-art precision machine tools and equipment to ensure that the most complicated designs meet the highest quality standards.

“On behalf of the CatapultMD team, we are pleased that Tyber Medical will be the new owner of this business, enabling it to further flourish for the benefit of our customers and beyond,” said CatapultMD President and founder Oliver Zaiser.

The acquisition gives Tyber Medical access to the diverse customers that CatapultMD currently serves. “We are very excited to serve these medical device companies and welcome them into our Tyber Medical customer family,” said Tyber. “Our business is based on filling gaps in our customers’ product portfolios by bringing FDA-cleared, MDR-compliant, and CE-approved medical devices to market for them in less than 12 months. Our acquisition of CatapultMD will help us ensure that our integrated supply chain will continue to meet our critical speed to market metric.”

The transaction is expected to close before the end of the year.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy